StemRx: Carry your Repair Kit with Yourself

You may surprise after reading the title but it is true that you carry your repair kit with yourself naturally.  i.e. your stem cells. Stem cells are biological cells found in all multicellular organisms that can divide (through mitosis) and differentiate into diverse specialized cell types and can self-renew to produce more stem cells.

Stem cells are the most promising tools in combating genetic disorders and human diseases such as diabetes, cancer, Parkinson’s disease, heart disease, etc., which are difficult to treat by conventional therapeutic methods. Even though all kinds of stem cells have potential uses, the embryonic type is easier to extract and believe to have more advantages as compared to the adult stem cells and induced stem cells.
There are three accessible sources of autologous adult stem cells in humans:
·         Bone marrow
·         Adipose tissue (lipid cells)
·         Blood
Most stem cells are in your bone marrow. You also have some in your blood that circulate from your bone marrow. Bone marrow stem cells turn into red blood cells, white blood cells, or platelets to help your body stay healthy.
At StemRx team of stem cell researchers will treat your disease or injuries with autologous stem cells therapy. Autologous cell therapies are emerging therapeutic intervention where it introduces or uses cells or tissues from your blood, then cultured, expanded and re-introduced at the site of the your disease. They are widely promoted as next pillar or advancement in medical care.
Let me explain by an example.  If your bone marrow is attacked by a disease such as multiple myeloma, it can no longer make normal blood cells. In a stem cell transplant, healthy stem cells are placed in your body through an IV (Intravenous) to help your bone marrow start to work right.
When the stem cells come from your own blood or bone marrow, it is called an autologous transplant. StemRx have treated hundreds of patients through its internationally accepted autologous stem cells treatments.
For More info visit www.stemrx.in
Advertisements

Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.

Transplantation of mesenchymal stem cells (MSCs) derived from bone marrow has been shown to improve functional outcome in spinal cord injury (SCI). Systemic and intrathecal delivery of MSCs results in therapeutic benefits in a number of experimental central nervous system disorders.

In the present study we transplanted MSCs derived from bone marrow through Lumbar Puncture at various time intervals after transplantation of a severe contusive SCI to study their therapeutic effects. MSCs were systemically delivered at varied time intervals (6h to 28 days after SCI).

The availability of autologous MSCs in large number and the potential for systemically delivering cells to target lesion areas without neurosurgical intervention suggests the potential utility of intravenous cell delivery as a prospective therapeutic approach in acute and subacute SCI.